Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Kathleen A Fairman, Lindsay E Davis, David A Sclar Department of Pharmacy Practice, College of Pharmacy, Midwestern University-Glendale, Glendale, AZ, USA Background: Inconsistency of real-world medication use with labeled indications may affect cost and clinical value of pharmacotherapy. PCSK-9 inh...

Full description

Saved in:
Bibliographic Details
Main Authors: Fairman KA (Author), Davis LE (Author), Sclar DA (Author)
Format: Book
Published: Dove Medical Press, 2017-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!